FDA to Crack Down on Stem Cell Clinics With Unproven Therapies – Bloomberg Law

Hundreds of U.S. stem cell clinics selling experimental therapies without an FDA permit can expect to face the agencys enforcement arm and potential action from the federal government.

The Food and Drug Administration ended a three-and-a-half year grace period Monday designed to allow these clinics to come into compliance with its 2017 regenerative medicine policy. The agency has worked with federal law enforcement agencies to shut down the most egregious cases, including one that made several women blind.

Peter Marks, director of the FDAs Center for Biologics Evaluation and Research, has made clear for years that the agency will be stepping up its enforcement over these unproven treatments once the discretion period ends. It was supposed to end last November, but the FDA provided a six-month extension due to the pandemic.

Its a high priority that we get the message out there, that these products need investigational new drug applications, or should have a biologic license application submitted, or they should not be marketed, Marks said at the Food and Drug Law Institutes annual meeting May 20.

Clinics that sell these treatments say they are surgical procedures that dont require FDA regulation. The agency counters that these companies are making unproven and potentially harmful claims about products that fall under its regulations for human cells, tissues, and cellular and tissue-based products, or HCT/Ps.

The agency doesnt oversee what it defines as minimal manipulation of HCT/Ps, but thats a designation for procedures such as bone marrow transplants, which have been used in medical care for decades, to proceed without FDA oversight. The clinics offering the new and unproven treatments typically take someones fat cells and reprocess them into stem cells, with claims that these cells can treat a range of diseases from Parkinsons to heart disease and even Covid-19.

All cell therapies should be proven safe and effective in well-regulated clinical trials before being marketed to patients. In recent years, increasing numbers of patients have been harmed by such therapies, Sean Morrison ISSCR public policy committee chair and director of the Childrens Medical Center Research Institute at UT Southwestern, said in a statement to Bloomberg Law. We hope increased FDA enforcement will reduce the number unscrupulous clinics that take advantage of desperate patients.

The International Society for Stem Cell Research said it welcomed increased FDA enforcement of its regulations against the marketing of unproven cell therapies.

Its really time for FDA to start aggressively enforcing the law to protect patients from these products, which are risky, Liz Richardson, project director of health-care products for The Pew Charitable Trusts, said in an interview. They often cost people, not just in terms of their health, but in terms of their money, because a lot of these treatments are paid for out of pocket.

These clinics have harmed hundreds of patients since theyve proliferated, Pew found in a report released Tuesday on its health projects website. Pew identified 360 people harmed between 2004 and September 2020 by stem cell injections and other regenerative therapies. The data came from adverse events reports from medical literature, submissions to the FDAs adverse event reporting system, government publications, news articles, and online consumer reviews of stem cell businesses such as Google and Yelp.

Pew identified at least 21 patient deaths, as well as injuries that included life-threatening infections, blindness, cardiac arrest, and the growth of tumors and lesions.

Those incidences are probably much lower than the level of harm thats actually happening, Richardson said. We know that adverse events are underreported for any medical products, including those that are FDA regulated, and theres mandatory reporting involved. But for this, these products that are unapproved and unproven, the rate of underreporting is probably much higher.

While Richardson said she wants the FDA to be more aggressive in going after these clinics, she acknowledged there are limits on the agencys ability to pursue hundreds of clinics at once. Markss center is small and also regulates vaccines, monoclonal antibodies, convalescent plasma, and blood, and there are about 900 active investigational new drug applications for cell and gene therapies.

Pew will be tracking the agencys enforcement effort over the next several months.

Its important to acknowledge that there are limitations in what the agency can do, certainly, given their chronic underfunding. Thats a reality, Richardson said. It probably will be a slow ramp-up, given just the fact that we are still in the middle of a pandemic.

The Federal Trade Commission also has authority over businesses making illegal claims, and state medical boards and attorneys general also can make strides in protecting patients from potentially dangerous products, Richardson said. Its not just the FDAs job. Theres a role for other regulators in this space.

View original post here:
FDA to Crack Down on Stem Cell Clinics With Unproven Therapies - Bloomberg Law

Global NK Cell Therapy and Stem Cell Therapy Market Stock Analysis, Impact of COVID-19 on Sales, Business Opportunities, Trends 2020 (Chipscreen…

GlobalNK Cell Therapy and Stem Cell Therapy marketexamines changing market conditions and keeps you ahead of rivals. It includes incredibly useful information for new and growing businesses to categorize themselves on the market. NK Cell Therapy and Stem Cell Therapy Market report also encompasses the worlds regions and states, which demonstrate a status for regional development. The study will define an important portion of the marketplace and markets with respect to output, use, profits, and gross margin.

Top listed players for the global NK Cell Therapy and Stem Cell Therapy market are,

Chipscreen Biosciences, Anterogen, Innate Pharma SA, Osiris Therapeutics, Altor BioScience Corporation, Takeda Pharmaceutical, NuVasive, Pharmicell, Affimed NV, Molmed, Chiesi Pharmaceuticals, Medi-post, JCR Pharmaceutical

Browse an Exclusive Summarised Copy of Report @https://www.marketresearchstore.com/market-insights/nk-cell-therapy-and-stem-cell-therapy-market-812901

The report contains the expected CAGR calculated for the NK Cell Therapy and Stem Cell Therapy market based on past and present records of the NK Cell Therapy and Stem Cell Therapy market. The report provides comprehensive analysis of the NK Cell Therapy and Stem Cell Therapy market and the key developments in the market. The market research and analysis covers historical and projected market data, production, product information, price trends and geography-leading company shares of NK Cell Therapy and Stem Cell Therapy. First, the study segments the size of the market by volume and value, depending on product form and geography. Secondly, this report includes the present status and prospects for the future of the NK Cell Therapy and Stem Cell Therapy global market for NK Cell Therapy and Stem Cell Therapy.

NK Cell Therapy and Stem Cell Therapy Market 2020 Global Industry Research Report is a comprehensive as well as in-depth study on the development, production, distribution, patterns, and evaluation of the market. Moreover, this study also includes market size, the revenue share of each segment and its thread-segments, as well as estimated statistics. The research study provides important information on the business position of producers of NK Cell Therapy and Stem Cell Therapy and provides significant advice and recommendations to individuals and organizations involved in the sector.

By Application:

Research institutes, Regenerative medicine centers, Diagnostic centers, Hospital & clinics

Market by Region:North America Country (United States, Canada), South America, Asia Country (China, Japan, India, Korea), Europe Country (Germany, UK, France, Italy), and Other Country (Middle East, Africa, GCC)

For Detailed Information Read Our Product Specifications @https://www.marketresearchstore.com/market-insights/nk-cell-therapy-and-stem-cell-therapy-market-812901

You Can Also, Read Our Demanding Reports:

1.Near Field Communication Chips (NFC)

2.Age-related Macular Degeneration

See the original post:
Global NK Cell Therapy and Stem Cell Therapy Market Stock Analysis, Impact of COVID-19 on Sales, Business Opportunities, Trends 2020 (Chipscreen...

Stem Cell Manufacturing Market Size, Business Growth Tactics, Future Strategies, Competitive Outlook and Forecast to 2027 The Courier – The Courier

Data Bridge Market Research included report gives a comprehensive overview of the current and future phases of the examination for the assessed Forecast Period 2021-2027. Stem Cell Manufacturing market research report contains complete background analysis of industry, many exploratory approaches such as qualitative and quantitative analysis have been applied. The base year for calculation in the report is considered as 2019 while the historic year is 2018 which suggests how the Stem Cell Manufacturing market is going to perform in the forecast years by informing about the market definition, classifications, applications, and engagements. In the regional analysis section of the business report, it has been shown that how different regions and countries are growing in the worldwide market and have predicted their market sizes for the next few years. Stem Cell Manufacturing market report provides research innovations, management strategies, market drivers, challenges and visions, and comprehensive industry subdivision and distribution. The report explains the current state of the market around the world. The study starts with the market outline and key components of the market. The study additionally offers the key focuses to upgrade the development in the Stem Cell Manufacturing market.

Stem cell manufacturing marketis expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 18.59 billion by 2027 growing at a CAGR of 6.42% in the above-mentioned forecast period. The growing awareness towards diseases like cancer, hematopoietic disorders and degenerative disorders is going to drive the growth of the stem cell manufacturing market.

Download Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-stem-cell-manufacturing-market&AS

Top Key Players of the Market:

Detailed Market Analysis and Insights:

An all-inclusive Stem Cell Manufacturing market report studies the market and the industry thoroughly by considering several aspects. According to this market report, the global market is anticipated to observe a moderately higher growth rate during the forecast period. This makeover can be subjected to the moves of key players or brands which include developments, product launches, joint ventures, mergers and acquisitions that in turn change the view of the global face of the industry. With the actionable market insights included in this report, businesses can craft sustainable and cost-effective strategies. Stem Cell Manufacturing market document provides all-inclusive study about production capacity, consumption, import and export for all the major regions across the world.

Increase in the research and development activities in pharmaceutical and biotechnology sector, stem cell therapy including cell therapy and gene therapy along with animal biotechnology sector for the production of better yield is likely to accelerate the growth of the stem cell manufacturing market in the forecast period of 2020-2027.People ethics such as the embryonic stem cell research violates respect for human life and downward pricing of product owing to commodity is likely to hamper the growth of the stem cell manufacturing market in the above mentioned forecast period.

Segmentation Of Stem Cell Manufacturing Market:

By Product (Stem Cell Line, Instruments, Culture Media, Consumables)

By Application (Research Applications, Clinical Applications, Cell and Tissue Banking)

By End Users (Hospitals and Surgical Centers, Pharmaceutical and Biotechnology Companies, Clinics, Community Healthcare, Others)

ACCESS FULL REPORT:https://www.databridgemarketresearch.com/reports/global-stem-cell-manufacturing-market?utm_source=AS&utm_medium=AS

A persuasive Stem Cell Manufacturing report provides market sizing and segmentation, competitor shares and trend analysis. This market report is very useful to plan market expansion strategies. With this report, businesses can figure out markets that offer the greatest growth opportunities, competitors strategy, requirement of prospective clients and more. The report can answer specific questions to make critical decisions on the basis of real information and insight. Market research report provides detailed insights about the competitors, understands customers pain points & preferences, latest market trends, consumer buying patterns, economic shifts, and demographics. So, smart business owners never underestimate Stem Cell Manufacturing market research report and leverage it to creative effective strategies.

Competitive Landscape and Stem Cell Manufacturing Market Share Analysis

Stem cell manufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to stem cell manufacturing market.

The major players covered in the stem cell manufacturing market report are Thermo Fisher Scientific., Merck KGaA, BD, JCR Pharmaceuticals Co., Ltd., Organogenesis Inc, Osiris, Vericel Corporation, AbbVie Inc., AM-Pharma B.V., ANTEROGEN.CO.,LTD., Astellas Pharma Inc., Bristol-Myers Squibb Company, FUJIFILM Cellular Dynamics, Inc., RHEACELL GmbH & Co. KG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., ViaCyte,Inc., VistaGen Therapeutics Inc, GlaxoSmithKline plc, DAIICHI SANKYO COMPANY, LIMITED, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

To receive extensive list of important regions, ask for TOC here @https://www.databridgemarketresearch.com/toc/?dbmr=global-stem-cell-manufacturing-market&AS

Global Stem Cell Manufacturing Market Scope and Market Size:-

Stem cell manufacturing market is segmented on the basis of product, application and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Table of Content

Global Stem Cell Manufacturing Market Research Report

Important Features that are under Offering and Key Highlights of the Reports:

Detailed overview of Stem Cell Manufacturing Market

Changing market dynamics of the industry

In-depth market segmentation by Type, Application, etc.

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape of Stem Cell Manufacturing Market Products

Strategies of key players and product offerings

Potential and niche segments/regions exhibiting promising growth

On the Basis of Region

The report is mainly segmented into several key regions, with sales, revenue, market share and growth rate of Stem Cell Manufacturing in these regions, from 2020 to 2027, covering:

U.S., Canada and Mexico in North America, Germany, France, U.K.

Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe

China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand

Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA)

Enquire Here for, Report Enquiry, Discount and Customization:https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-stem-cell-manufacturing-market&AS

Benefits of Buying The Report:

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:-corporatesales@databridgemarketresearch.com

See the original post:
Stem Cell Manufacturing Market Size, Business Growth Tactics, Future Strategies, Competitive Outlook and Forecast to 2027 The Courier - The Courier

Lymph nodes: Purpose, location, and disease warning signs – Medical News Today

Lymph nodes are small, bean-shaped glands that play a crucial role in the immune system. They filter lymphatic fluid, which helps rid the body of germs and remove waste products.

The body contains hundreds of lymph nodes. They form clusters around the body and are particularly prominent in areas such as the neck, armpit and groin and behind the ears.

The bodys cells and tissues dispose of waste products in lymphatic fluid, which lymph nodes then filter. During this process, they catch bacteria and viruses that could harm the rest of the body.

Lymph nodes are an essential part of the bodys immune system. Due to their function, they come into contact with toxins, which can cause them to swell. Although swollen lymph nodes are common, they may occasionally indicate lymph node cancer, or lymphoma.

Keep on reading to learn more about lymph nodes and their function within the immune system.

Lymph nodes are part of the lymphatic system, which is a complex network of nodes and vessels.

In certain areas of the body, such as the neck, armpit, and groin, lymph nodes sit close to the skin. This means a person may feel them swell when an infection develops.

Lymph nodes are also present in the stomach and between the lungs. However, there are no lymph nodes in the brain or spinal cord.

The name of a lymph node depends on its location in the body.

Lymph nodes form clusters throughout the body. Their main function is to filter out potentially harmful substances.

All tissues and cells in the body excrete lymphatic fluid, or lymph, in order to eliminate waste products. The lymph then travels through vessels in the lymphatic system and passes through lymph nodes for filtering.

Lymph nodes contain lymphocytes. These are a type of white blood cells that help destroy pathogens, such as bacteria, viruses, and fungi. When lymph nodes detect a pathogen in the lymph, they produce more lymphocytes, which causes them to swell.

Upon encountering bacteria or damaged cells, lymph nodes destroy them and turn them into a waste product.

When the lymph reenters the bloodstream, waste products travel to the kidneys and liver. The body then excretes waste products in the urine and feces.

Learn more about how the lymphatic system works here.

Swollen lymph nodes do not always indicate cancer. Below, we list some of many conditions that can cause lymph node swelling.

Lymphadenitis occurs when bacteria, viruses, or fungi in the lymph infect lymph nodes. When this happens, lymph nodes swell and are painful to the touch.

If multiple clusters of nodes become infected, a person may feel pain and swelling in both their neck and groin.

The most common type of lymphadenitis is localized lymphadenitis. This means the condition only affects a few nodes. If the infection occurs in several node clusters, a doctor will likely diagnose generalized lymphadenitis.

The condition usually results from an infection elsewhere in the body.

Symptoms of lymphadenitis include:

Lymphadenitis treatments include:

The type of treatment necessary will depend on a variety of factors, such as the severity of the disease and a persons underlying conditions and allergies. A doctor will help a person choose the most suitable treatment based on these factors.

Learn more about swollen lymph nodes in the neck here.

Swollen lymph nodes in the neck may be due to a viral or bacterial throat infection, such as strep throat.

Viral throat infections, such as colds, can present with swollen lymph nodes, a runny nose, and pinkeye.

These infections usually resolve on their own. However, a person can take over-the-counter pain relievers to alleviate pain they may experience when swallowing.

Strep throat is a bacterial infection that develops in the throat and tonsils due to group A streptococcus. People may contract strep throat if they come into contact with droplets containing the strep bacteria.

A person with strep throat may experience swollen lymph nodes on the neck, a sore throat, a fever, and red spots on the roof of the mouth.

Doctors treat strep throat with antibiotics.

Impetigo is an infection that develops due to group A streptococcus and may cause lymph nodes in the armpits and groin to swell.

A person can contract impetigo when the bacteria enter the body through a break in the skin. This can happen through sharing a towel, razor, or yoga mat.

Symptoms of impetigo include:

If a person has impetigo, they should seek medical attention to address their symptoms and prevent the condition from spreading to others.

Treatment will usually involve antibiotics.

Ringworm, or jock itch, is a fungal infection that can affect many areas of the body. If the fungus develops in the groin, a person may experience lymph node swelling in that area.

Typically, ringworm starts as a fungal lesion. The fungus often transmits when people share towels or razors.

Ringworm thrives in moist environments, and therefore a person should take care to dry thoroughly after a wash and try not to stay in damp clothes.

Common ringworm symptoms include:

A doctor will prescribe an antifungal treatment to address ringworm.

The best way to prevent ringworm is to wear breathable fabrics, avoid sharing towels and razors, and dry thoroughly after bathing.

Learn more about swollen lymph nodes in the groin here.

Lymphoma is a type of cancer that affects the lymphatic system. The two main types of lymphoma are Hodgkin lymphoma and non-Hodgkin lymphoma.

Hodgkin lymphoma occurs when cancer cells spread from one cluster of lymph nodes to another. By contrast, in non-Hodgkin lymphoma, there is no order in how cancer cells spread throughout the lymphatic system.

Typical symptoms of lymphoma include:

These are also common symptoms of viral infections, which can make lymphoma hard to diagnose. However, in people with lymphoma, symptoms tend to persist for longer periods of time.

It is of note that these symptoms do not clearly indicate cancer. If a person experiences any of these, they should contact a doctor to identify the cause of their symptoms.

Treatment options for lymphoma include:

A person should contact a healthcare professional if they are experiencing persistent swelling of lymph nodes.

Swelling usually indicates an infection, and therefore a person should not immediately worry about lymphoma.

After reaching a diagnosis, a doctor will recommend the appropriate course of treatment.

Lymph nodes are a part of the lymphatic system. They filter lymph, which contains pathogens and damaged cells, and send the dead cells to the kidneys and liver.

Lymph node swelling usually results from an infection. In rare cases, however, it may be due to lymphoma.

If a person is concerned about swelling and other symptoms they have, they should contact a doctor.

The rest is here:
Lymph nodes: Purpose, location, and disease warning signs - Medical News Today

Teesside baby will be third in country to have ground breaking complex cancer treatment – Teesside Live

Teesside tot Olivia-Grace Corcoran was flying to London with her family today to start ground breaking treatment in a bid to cure her leukaemia.

The six month old, from Dormanstown, near Redcar, will become only the third person in the country - and the youngest - to undergo a complex and specialist treatment called CAR T cell therapy.

She was diagnosed with a form of acute leukaemia in March at the age of just four months after starting to repeatedly vomit her baby milk back up.

The beautiful little girl, who her family describe as nothing short of amazing, has already undergone chemotherapy to try to beat the disease and was due to have a stem cell transplant at Newcastle's RVI.

Instead, doctors have taken the decision to fly her to London's Great Ormond Street Hospital for the highly specialist treatment in a bid to stabilise her condition.

Her dad Jordan, 22, a plumber, and mum Chloe Kirk, 20, will fly with her to the hospital on Tuesday, June 8, for initial tests. She'll then have to spend three months in the capital whilst the complex procedure is carried out.

Jordan said he hasn't had time yet to process the enormity of the situation, instead the young family are concentrating their energy on Olivia-Grace and tackling things as they come.

"It came as a shock when they said go to London, we weren't expecting it," said Jordan.

"We thought we'd be in the RVI in Newcastle but after speaking with the doctors, they wanted to do this new therapy at Great Ormond Street Hospital.

"Olivia-Grace is fine, she's really content and she just seems to get on with things really well."

CAR T cell therapy involves taking a sample of T cells from the blood - the type of cells that fight infection and diseases. They are then taken to a lab and genetically modified to try and get them to recognise cancer cells.

Once they have grown and multiplied, the cells are then dripped back into the bloodstream. The aim is for the CAR T cells to then attack the cancer cells.

In Olivia-Grace's case, says Jordan, the initial T cells will come from an adult blood donor.

The family have been told she is only the third person to have it, and the youngest.

"It makes you wonder who thought of doing that in the first place - but whoever it was, thank you," said Jordan.

After initial bone marrow tests, the young family hope to be back on Teesside on Wednesday. From then, depending on results, Olivia-Grace will have to spend three months at the London hospital.

If the CAR T cell therapy works, the hope is she'll then be able to have a stem cell transplant as planned.

Chloe will stay with her, says Jordan, and the hope is that his mum will be able stay with them too. Jordan works full time but hopes he'll be able to travel up and down to Great Ormond Street Hospital every weekend to be with his family.

To sign up for Teesside Live news updates, go here

The Dormanstown community have already rallied round with their support by organising a number of fundraising initiatives to help the young family. You can find their GoFundMe page here.

Originally posted here:
Teesside baby will be third in country to have ground breaking complex cancer treatment - Teesside Live

Local veterinary clinics offer integrated care options for pets – williamsonherald.com

After graduating from the University of Tennessee College of Veterinary Medicine and practicing in the field for several years, Dr. Mitch McKee began to explore alternative treatment methods that would improve his four-legged patients lives, working collaboratively with conventional treatments and therapies.

McKee went on to pursue various accreditations in holistic veterinary medicine from Chi University in Reddick, Florida, including a masters degree in traditional Chinese veterinary medicine, making him one of only approximately 300 people across the country with this certification.

He now incorporates these accreditations and practices into his treatments daily for patients at both Cupola Animal Hospitals locations, including Berry Farms Animal Hospital in Franklin and Concord Road Animal Hospital in Brentwood.

Using both traditional and holistic methods of medicine allows us to provide our patients and their owners with the best of both worlds, McKee said. Western medicine is great, we love it and need it, but its more of a one-size-fits-all method. You tend to treat the problem and not the patient. With an integrated approach, Chinese methods and holistic practices allow us to individualize therapy so that we treat the underlying issue that led to the problem at hand, often with fewer side effects.

McKee and his fellow certified veterinary acupuncturist at Cupola, Dr. Ben Larson, are among just a handful of veterinarians in the Middle Tennessee area qualified to use acupuncture, and they utilize it as a treatment option regularly. Both clinics offer three types of acupuncture, which has been shown to initiate healing and decrease pain to improve a patients quality of life.

The clinics also offer chiropractic care, food therapy, massage therapy, herbal medicine, stem cell therapy, and ozone (O3) therapy in addition to acupuncture, treatment options the doctors recommend for a number of animal patients.

Any patient, regardless of age or medical issue, can benefit from these integrated therapies, McKee said. You can utilize them one time for a particular situation, or monthly, or however often you need to. Theres a great deal of flexibility with offering multiple modalities of therapy, and weve found that using them can decrease the need for expensive or risky surgeries. We have witnessed countless success stories with our patients that demonstrate these treatment options are effective and reliable.

Berry Farms Animal Hospital recently celebrated its fourth anniversary in March, and Concord Road celebrated its second anniversary last month. To learn more about the clinics or to make an appointment, visit CupolaAnimalHospitals.com.

Follow this link:
Local veterinary clinics offer integrated care options for pets - williamsonherald.com

Brave Nathaniel Nabena, 9, all smiles as he has life-saving procedure – thanks to you – The Mirror

Brave Nathaniel Nabena smiles from his hospital bed moments before a life-saving procedure.

The nine-year-old had a vital stem cell transplant at Great Ormond Street Hospital on Wednesday after Sunday People readers helped raised more than 215,000.

Nathaniel, battling acute myeloid leukaemia, was on a drip for 30 minutes as umbilical cord stem cells were fed into his body.

Afterwards, dad Ebi said: Nathaniel is very happy. It was amazing to finally get to this point we have all been waiting for.

The youngster was admitted a fortnight ago and had five doses of chemo over ten days to prepare him for the procedure.

How brave has Nathaniel been? Have your say in comments below

Mum Modupe, 38, was able to spend time with him before his transplant.

Consultants warn he faces weeks of sickness as his body reacts to the new cells with symptoms including vomiting and a fever.

Ebi, 45, said: His doctors hope to see improvements after five weeks. It is so hard to see him so exhausted but I dont have a choice. We are grateful to have this done. Our fingers are crossed to see what happens.

For now, Nathaniel has a compromised immune system and is susceptible to falling ill, so he will be staying on the ward.

Stars including Simon Cowell, David Walliams, Katie Price and JLS singer Aston Merrygold rallied to support him after we told of the desperate race to fund treatment.

Nathaniels left eye was removed in his home country of Nigeria a year ago, due to myeloid sarcoma cancer. He was diagnosed with AML in the UK in November after coming here to have a prosthetic eye fitted.

Nathaniel was told a stem-cell transplant was his only hope for survival but it would cost 201,000 as he is not a British citizen. Ebi and Modupe were initially told it could cost as much as 825,000 but the figure was revised after doctors waived their fees and offered to treat him in their own time.

The Mirror's newsletter brings you the latest news, exciting showbiz and TV stories, sport updates and essential political information.

The newsletter is emailed out first thing every morning, at 12noon and every evening.

Never miss a moment by signing up to our newsletter here.

The lad was admitted to GOSH on May 24 after generous Brits rushed to help the family raise cash.

Business analyst Ebi, who is staying at the hospitals family quarters, said: Ive been there the whole time. When he is not sleeping he is passing the time playing his games.

We sometimes talk about when he gets better and how exciting that will be. This is a difficult thing for him to go through, but Nathaniel is being brave, he is well in himself.

In acute myeloid leukaemia, unhealthy blood-forming stem cells grow quickly in the bone marrow.

This prevents it from making normal red blood cells, white blood cells and platelets meaning the body cannot fight infections or stop bleeding.

A stem cell transplant, also known as a bone marrow transplant, can help AML patients stimulate new bone marrow growth and restore the immune system.

Before treatment, patients need high doses of chemo and sometimes radiotherapy.

This destroys existing cancer and bone marrow cells and stops the immune system working, to cut the risk of transplant rejection.

In an allogeneic transplant, stem cells are taken from a family member, unrelated donor or umbilical cord blood. In Nathaniels case, it was from a cord.

They are then passed into the patients body through a line inserted in a large, central vein, in a process that takes up to two hours.

You can also remove stem cells from the patients body and transplant them later, after any damaged or diseased cells have been removed this is called an autologous transplant.

The survival rate after a transplant for patients with acute leukaemia in remission and using related donors is 55% to 68%, according to Medicine Net. If the donor is unrelated, it is 26% to 50%.

See the original post:
Brave Nathaniel Nabena, 9, all smiles as he has life-saving procedure - thanks to you - The Mirror

Blood cancer and leukaemia: UAE oncologist urges public to spot the symptoms – The National

A leading oncologist has urged the public to be aware of the symptoms of blood cancer and leukaemia amid a global rise in new cases.

Dr Shahrukh Hashmi, chair of the haematology and oncology department at Abu Dhabi's Sheikh Shakhbout Medical City, said too many cases were diagnosed in the advanced stage.

Leukaemia is a group of blood cancers that usually develop in the bone marrow and the lymphatic system.

It is among the 10 most prevalent cancers globally and according to studies has been on the rise in recent years. The five-year survival rate in the United States is about 57 per cent.

The one thing that the public can take charge of is active surveillance, with regular pap smears, colonoscopies and mammograms

Dr Shahrukh Hashmi, Sheikh Shakhbout Medical City, Abu Dhabi

We have hundreds of cases recorded every year but it is very likely that there are even more that go unrecorded, because many go underdiagnosed or misdiagnosed," said Dr Hashmi, a specialist in late-stage chemotherapy treatment and cancer survivability.

Less is known about the causes of leukaemia and lymphoma than many other cancers. Exposure to certain chemicals, genetic disorders, family history and smoking are known to be factors.

Some studies have linked blood cancers to a rise in pollution.

Dr Hashmi believes more research is needed in the Gulf and UAE to understand the causes.

He said environmental factors could play a part, along with "inheritable cancers due to consanguineous marriages".

We have not yet had any epidemiological studies giving the exact cause of the significantly higher ratio of blood cancers to solid cancers in the UAE," he said.

_______________________

- fever or chills

- persistent fatigue, weakness

- frequent or severe infections

- losing weight without trying

- swollen lymph nodes, enlarged liver or spleen

- excessive sweating, especially at night

Source: Mayo Clinic

_______________________

Dr Hashmi said too many patients shuttle between smaller hospitals and undergo a myriad of referrals before they reach a specialist cancer ward.

The biggest problem I see here is the dissipation of care. Many patients will go to several hospitals before finally landing at tertiary care centres like SSMC," he said.

By the time they come here they already have been to three or even four hospitals which delays care.

Last month, a study shed light on the high prevalence of cancer in UAE and Saudi Arabia.

The analysis of 2017 data from major developed countries showed almost half of all cancer cases in the UAE involved people aged under 50.

Dr Abdulmajeed Alzubaidi takes The National on a tour of the facilities

Abu Dhabi's new Sheikh Shakhbout Medical City opened towards the end of 2019. All photos by Chris Whiteoak / The National

A sculpture in the foyer of the sprawling hospital

The emergency department can handle hundreds of patients

The hospital is located on a large campus outside the city

A state-of-the-art surgical theatre

Floor to ceiling windows allow for plenty of natural light

The hospital is jointly run by America's top-ranked medical group - Mayo Clinic - and Abu Dhabi public hospital operator Seha

A view from outside Sheikh Shakhbout hospital

An air conditioned walk way connects hospital wings and parking facilities

The hospital's location allows for large rooms and wards

The facility has taken over patients and services from older public hospitals

The facility has taken over patients and services from older public hospitals

The facility has taken over patients and services from older public hospitals

The facility has taken over patients and services from older public hospitals

The facility has taken over patients and services from older public hospitals

The facility has taken over patients and services from older public hospitals

The facility has taken over patients and services from older public hospitals

The studys authors, from University of Sharjah's College of Medicine, said the trend was a "critical issue that is currently underreported".

As with global trends, breast cancer was most prevalent accounting for 36 per cent of all cases followed by several forms of colorectal cancers.

The latter in particular is closely linked to lifestyle choices, including bad diet, smoking and drinking alcohol.

Dr Hashmi said better lifestyles, high public awareness and regular screening of people of all ages will save lives.

"The one thing that the public can take charge of when it comes to cancer is active surveillance," he said.

"People should get regular screenings for cancers such as pap smears, colonoscopies and mammograms. These are preventative measures that have been around for decades in Europe and the US.

"Our screening rates are low and we are really hoping it can go up, especially for the most common cancer we know of, breast cancer.

For blood cancers, some of the common symptoms are fatigue and persistent swollen lymph nodes.

Acute leukaemia patients will generally need a bone marrow or stem cell transplant.

Despite advances in the UAE's organ transplant programme, including the first bone marrow transplant in 2020, many patients travel abroad for treatment.

Sheikh Shakhbout Medical City will have its own transplant centre set up by the final three months of 2021.

For patients such as 34-year-old Mohammad Hoda, an electrician who works for a company in Abu Dhabi, it cannot open too soon.

He is undergoing chemotherapy at SSMC and his doctors are working with hospitals in India to try to find a suitable donor for a bone marrow transplant.

The Indian father-of-four was found with advanced leukaemia just over a month ago.

"I was feeling very tired and had severe pain in my body. I also had a few nose bleeds," he said.

When The National visited his hospital room last week, he was hopeful that medics in India will find a match, giving a thumbs up as he posed for a photograph.

But like all organ transplant patients, has no way of knowing if and how long it could take to find a donor.

"It is hard that I am alone here without my family, and my future is uncertain," he said.

View original post here:
Blood cancer and leukaemia: UAE oncologist urges public to spot the symptoms - The National

Replotting the human: the thorny ethics of growing babies outside the womb – Prospect

In its worthy pursuit of what the philosopher Francis Bacon called the relief of mans estate, science has a habit of creating previously unknown moral dilemmas. Thats nowhere more apparent than in the sciences pertaining to the beginning of human lives.

When IVF took off after the birth of Louise Brown in 1978, fertility doctors were faced with the question of what to do with embryos produced in vitrothat is, outside the wombwhich would not, either because of their unviability or sheer excess in number, be implanted for gestation. Many were donated for embryological research, which has made huge strides as a result. But this has also complicated the already impassioned argumentsstill unresolvedabout the moral status of the human embryo.

Similar wrangles loom over the recent report in Nature by a team of scientists based in Israel who say that they can gestate mouse embryos in glass jars for up to 12 days. That might not sound long, but it is half a mouses normal gestation period: the embryos can reach a stage where the internal organs are in place, the heart is beating, and the hind legs are developing.

By contrast, no human embryos have been grown outside the womb beyond 14 days (the legal limit in the UK, Israel, China and many other countries), which is of course still at a very early stage of the journey towards becoming a baby. But Jacob Hanna, who led the Israeli project at the Weizmann Institute of Science, told Technology Review that it sets the stage for other species I hope that it will allow scientists to grow human embryos until week five.

At the same time, advances in biology are enabling the creation of entirely new types of embryo-like structures, which some call simbryos, by assembling from scratch the embryonic cells of humans and other animals. Because these entities are in some sense artificial, though made from ordinary living cells, researchers arent sure if they qualify as genuine embryos, and so whether they should fall under the 14-day legal constraint. Meanwhile, scientists in the US and China have recently reported making chimeric embryos that contain a mixture of human and monkey cells, which they could keep alive in vitro for up to 20 days.

All these studies are motivated by biomedical questions and needs, from trying to understand the early stages of human development (and what can go wrong, for example, leading up to miscarriages) to trying to grow human organs for transplants within livestock animals. Yet they are also blurring boundaries: between natural and artificial, tissue culture and actual conception, humans and other species. We are, in the words of academic Susan Merrill Squier, replotting the humanand, so far, with no moral framework to guide us.

We havent even decided what the important questions are, let alone how to answer them

When the Warnock Committee, chaired by moral philosopher Mary Warnock, was established in 1982 to navigate the thicket opened up by IVF, it intentionally ducked the issue of the human embryos moral status. A key strategy of the Warnock Committee, says Sarah Franklin, director of the Reproductive Sociology Research Group at Cambridge, was to eschew the moral debate, for the simple reason it can never be resolved. The committees recommendation of the 14-day rule was pragmatic: this is roughly the point after which an embryo cannot split into twins, and so served as an otherwise entirely arbitrary kind of proxy for personhood. No more rigour was needed because there was not at that stage any practical possibility of going beyond that line.

But technological advances mean that governments and scientific bodies are reconsidering the 14-day ruleand thereby taking the lid back off the moral debate. Simbryos might simply sidestep itbut should they? These are dilemmas that science has created but cannot answer. The great danger is that, amid the murk, we will grab onto polarised ideologies in the hope of settling things.

Eugenic hatcheries

Arguments about embryology have long been divisive, and come weighted down with heavy cultural baggage. Growing embryos and even babies ex utero was christened ectogenesis in the early 20th century; its possibility motivated the biologist JBS Haldane to write Daedalus, or Science and the Future in 1924. Haldane presented a fictionalised future in which ectogenesis was introduced in the 1950s to combat plummeting birth rates. His narrator explains that, by 2073, less than a third of children were still born of woman.

Haldane welcomed this prospect. First, he said, it would allow population increase to be rationally planned and controlled. Better still, it would be possible to control who reproduced. Like many of his progressive contemporaries, while he supported female emancipation, he worried that better educated, well-bred women would prefer their new opportunities over their traditional role as mothers, leading to a decline in the quality of the gene pool. Ectogenesis could facilitate the necessary corrective of eugenic engineering. An enthusiasm for eugenics was shared by Haldanes friend Julian Huxley, who served as vice president and then president of the British Eugenics Society from 1937 to 1962. (No, eugenic advocacy was not killed off by the example of the Nazis.)

But Huxleys brother Aldous was less taken with Haldanes vision of a bioengineered population grown in artificial wombs. That scenario supplied the inspiration for the dystopian Brave New World (1932), with its hatcheries in which foetuses are chemically manipulated for intelligence to create the hierarchical society of the World State.

At one time, both men and women sympathetic to the feminist cause welcomed ectogenesis. In Hymen, or The Future of Marriage (1927), Norman Haire suggested that animals might instead act as gestational surrogates: human babies born to chimp mothers, for example. The pioneering feminist Vera Brittain, however, conceded in Halcyon, or the Future of Monogamy (1929) that natural methods of reproduction might make a comeback after a period of ectogenesis because children born outside the womb could suffer psychological problems. The trailblazing feminist writer Shulamith Firestone was another fan of ectogenesis. Her 1970 book The Dialectic of Sex portrayed childbearing as a primary cause of gender inequality: I submit, she wrote, that the first demand for any alternative system must be the freeing of women from the tyranny of their reproductive biology by every means available.

For all its humanitarian objectives, embryonic research remains ethically fraught

In stark contrast, more recent feminists have warned that artificial wombs could remove from women a source of social power. Australian sociologist Robyn Rowland worries: We [women] may find ourselves without a product of any kind with which to bargain if that last power is taken and controlled by men, what role is envisaged for women in the new world? Will women become obsolete? Another worry is expressed by bioethicist Rosemarie Tong, who fears a commodification of the whole process of pregnancy [and] a view of the growing child as a thing.

History shows, then, that while putative reproductive technologies like ectogenesis and artificial wombs have long been controversial, the terms of the debate have shifted with social perceptions and attitudes. We havent even decided what the important questions are, let alone how to answer them.

Towards artificial wombs

True ectogenesis is still a far cry from what the Israeli group has just achieved. Their mouse embryos do not really exist in an artificial womb as such; they float freely in a nutrient medium, including human blood serum taken from the umbilical cord, in rotating glass jars kept at a carefully controlled temperature and in levels of dissolved oxygen elevated above normal. Because they have no placenta to attach to or umbilical cord to supply blood, eventually they die through lack of oxygen.

The work is impressive, but growing small mammal embryos far into gestation in artificial cell-culture conditions is not completely new. For example, developmental biologist Lynne Selwood at the University of Melbourne has been able to culture embryos of the stripe-face dunnarta mouse-like marsupialto within a few hours of full term. (Their gestation period is 11 days, the shortest of any mammal, and marsupials are born premature relative to other mammals.) Selwoods interest in the technique was its potential use for conservation: breeding and preserving the species from frozen embryos, for example.

Only in the past few years have researchers, such as Magdalena Zernicka-Goetz at Cambridgeone of Prospects World Top 50 Thinkers last yearmanaged to grow human embryos in vitro right up to that 14-day limit. The difficulties, both practical and ethical, of investigating human embryos inside the womb mean that plenty remains unknown about their genetics, cell biology and tissue and organ formation. Ex utero studies beyond two weeks could potentially help us to understand and avoid, for example, miscarriages and growth defects that might cause disability or even death for babies carried to full term.

You neednt be a pro-lifer to accept there is still an urgent need to think all the consequences through

For all its humanitarian objectives, though, such research remains ethically fraught. A five-week-old human embryo, say, is very different from the shapeless mass of cells and folded tissues at 14 days: it has a shrimp-like form, with a rudimentary head, a neural tube that eventually becomes the central nervous system and brainas well as a beating heart. In other words, it is more recognisably human. (When the foetus can potentially feel pain is not clearthat has generally been deemed impossible before the brains cortex matures at around 24 weeks, but some argue that pain of a kind, if not an awareness of suffering, might be registered as early as 12 weeks.)

Of course, abortion of such embryos is permitted well into pregnancy in many countriesup to 24 weeks (and in exceptional cases later) in Great Britain. But technologies for gestation in artificial wombsboth for the early embryo as in the latest Israeli work, and life support for very premature babiescould seriously complicate the legal and ethical dilemmas. If these two methods, coming from opposite directions, meet in the middle so that the entire gestational period becomes technologically supportable, then genuine Huxlerian ectogenesis becomes an option. Women with potentially life-threatening pregnancies might then no longer be faced with termination as the only optionbut the law doesnt currently cover such a scenario. And how would abortion rights fare in the face of a putative technological solution that can preserve the life of the embryo or foetus? Its far from inconceivable that a state with strong anti-abortion leanings could mandate continued ex utero gestation rather than termination.

Such questions remain hypothetical: creating true artificial wombs is challenging, and the field has advanced at a snails pace for decades. But the latest work by Jacob Hanna and colleagues is a reminder of the direction of travel.

Sustaining human embryos beyond 14 days would not, however, currently be done with reproduction in mind. The aim is basic research for understanding developmental biology. An alternative approach for doing that, which would evade the 14-day rule, is to build synthetic embryo-like structures from stem cells. In the right conditions, you dont need to do much more than bring the right sorts of cells togetherthey will organise themselves spontaneously into a configuration more or less resembling an embryo. Two teams in the US and Australia have recently described the in vitro generation of human blastoidsstructures similar to early-stage embryosfrom stem cells either taken from actual embryos or reprogrammed from adult skin cells. These blastoids resemble the so-called blastocyst, the stage that a human embryo reaches around five to nine days after fertilisation, when it is ready to implant in the uterus wall. The blastoids contain not only the mass of stem cells that will become the foetus, but also the cell types that can develop into the tissues needed to sustain and contain it: the yolk sac and the placenta. The team in Texas showed that their blastoids could attach themselves to the culture dish to mimic uterine implantation, and then continue to develop.

Blastoids are just one example of what some have dubbed synthetic human entities with embryo-like features (SHEEFs); though simbryos is a catchier name. As they are not made by fertilisation of an egg by sperm, their legal and ethical status is unclear, and there is no consensus on regulation. UK and EU patent law rules that a synthetic cellular entity cant be considered a human embryo if in the light of current scientific knowledge, it does not, in itself, have the inherent capacity of developing into a human being. In the US an absence of federal laws might mean that the guidelines of the International Society for Stem Cell Research (ISSCR) are adopted. These were revised in May, and advise that such research be governed by case-by-case considerationbut that such entities should not be transferred to the uterus of either a human or another animal. Current simbryos almost certainly couldnt develop into a foetus in any casebut as they become ever better mimics of natural embryos, we cant be sure what potential they might have. Whether they could become babies is a crucial question, says bioethicist Hank Greely of Stanford University in California, but can we resolve that ethically? We wont know without trying it in humanswhich we cant do.

The edge of human

This science is in a Catch-22 situation, Greely says. We want to do research about humans that we cant ethically do on humans, so we go to non-human models. Existing non-human models [such as animals] arent that good, so we make new, better modelslike simbryos. But the dilemma is the better the models getthe more human they arethe more we get back into the same ethical issues. Biotechnologies like simbryos and chimeric embryos, suggest Greely and Bartha Maria Knoppers of McGill University in Montreal, are nibbling at the legal definition of what a human is.

The new ISSCR guidelines advise relaxation of the 14-day rule on human embryo research, to be replaced by a case-specific decision on what the limit should be. Changes to national legislation will be needed to enact this in many countries. But if that happens, some anticipate not only learning more about human embryo development but even harvesting nascent organs from such embryos, such as pancreases or kidneys, that might be grown further in vitro for transplantation. It might also be possible to use embryos grown for several weeks to test the safety of human gene editing, for example, to avoid some nasty genetic diseases.

History suggests that our response to disruptive technology will be highly dependent on contingent cultural preoccupations

Even with such potential medical benefits, you neednt be a pro-lifer to accept there is an urgent need to think all the consequences through. Our ability to transform, manipulate and culture cells takes us into uncharted territory where the boundaries of natural and artificial, and even of the human and non-human, are blurred. No off-the-shelf moral framework can be expected to guide the should and shouldnt. And history suggests that our response to disruptive technology will be highly dependent on contingent and perhaps ephemeral cultural preoccupations and prejudices. To track a responsible and humane path forward, we needsomehowto try and look beyond them.

Scientists lack the training and often the desire to take on that role. But the stifling of stem cell and embryo research in the US by George W Bushs 2001 Council on Bioethics shows what happens when religious conservatives are given the reins. As that panel showed, bioethics is a label that covers a multitude of sins and sometimes shows no inclination to examine its own assumptions. And heaven forbid that these issues be allowed to become fresh fuel for the culture wars. If we can reconstitute the collective and pragmatic wisdom of the Warnock Committee, it wont be a moment too soon.

The rest is here:
Replotting the human: the thorny ethics of growing babies outside the womb - Prospect

Crossroads of life: Jordan Reed’s journey through concussions, injuries and post-NFL healing – The Athletic

LEESBURG, Va. The 2020 season had just ended, and tight end Jordan Reed already was imagining an improved version of himself for 2021. Only 30 years old, the tight end dreamt of what could be his best year yet.

Then, while he was meditating one morning in his home in Palo Alto, Calif., it started.

Ringing in his ears.

He had heard it before, but it never lasted. This time, it wasnt going away.

Sometimes it was audible, sometimes just vibration. At times it was loud; other times soft. It could be a high-pitched squeal, almost like a dog whistle, or sound like a breeze through a tunnel. Sometimes it was a low-pitched buzz, as if it came from a speaker with a wiring problem.

The ringing was there when he was showering, pumping gas, throwing punches at his trainers mitts and watching his daughters soccer practice. It was worse when he tried to sleep.

Visit link:
Crossroads of life: Jordan Reed's journey through concussions, injuries and post-NFL healing - The Athletic